Author:
Furuse Junji,Okusaka Takuji,Boku Narikazu,Ohkawa Shinichi,Sawaki Akira,Masumoto Toshikazu,Funakoshi Akihiro
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cancer Research,Pharmacology,Toxicology,Oncology
Reference32 articles.
1. Andre T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D et al (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol 15(9):1339–1343
2. Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S et al (2004) A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer 90(8):1516–1520
3. Falkson G, MacIntyre JM, Moertel CG (1984) Eastern Cooperative Oncology Group experience with chemotherapy for inoperable gallbladder and bile duct cancer. Cancer 54(6):965–969
4. Furuse J, Okusaka T, Funakoshi A, Boku N, Yamao K, Ohkawa S et al (2005) A phase II study of S-1 in patients with metastatic pancreatic cancer. Proc Am Soc Clin Oncol 23:16s (Abstract No: 4104)
5. Furuse J, Okusaka T, Funakoshi A, Yamao K, Nagase M, Ishii H et al (2006) Early phase II study of uracil-tegafur plus doxorubicin in patients with unresectable advanced biliary tract cancer. Jpn J Clin Oncol 36(9):552–556
Cited by
130 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献